Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
for Multiple Myeloma
36 locations incl. Birmingham
Sponsor: AbbVie
Sex: All·Age: 18+
Code: NCT06158841·Phase 3·Recruiting·Listed Dec 2023